Neurofilaments as Decay Rate Biomarker in Spinocerebellar Ataxia Type 1: Highlighting Key Questions of Application and Future Challenges

Neurology. 2022 May 17;98(20):821-822. doi: 10.1212/WNL.0000000000200360. Epub 2022 Mar 9.

Author

Benedetta Nacmias¹

Affiliation

¹ From the Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Italy.

PMID: 35264423
DOI: 10.1212/WNL.0000000000200360

No abstract available

Publication types

Editorial
Comment

MeSH terms

Biomarkers
Disease Progression
Humans
Intermediate Filaments*
Spinocerebellar Ataxias* / diagnosis
Spinocerebellar Ataxias* / genetics

Substances

Biomarkers